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AbstrAct
Objective Oral medicines are frequently modified 
(eg, tablets crushed) for older adults. However, these 
modifications can have clinical, legal and/or ethical 
implications. Nurses bear responsibility for medicine 
administration and hence, perform these modifications. 
The aim of this study was to investigate the knowledge, 
attitudes and beliefs of nurses about oral medicine 
modification for older adults.
Design A qualitative study was conducted using  
semi-structured, face-to-face interviews with nurses 
providing care to older adults in acute and long-term care 
settings. Interviews were audio-recorded, transcribed 
verbatim and analysed thematically.
settings Sixteen purposively selected care settings;  
4 acute-care and 12 long-term care settings were 
included. Nurses were recruited by convenience sampling 
at these sites.
Participants Eighteen nurses participated (83% female, 
67% long-term care, 33% acute-care, median age (IQR) 
38 years (32.5–52.0)).
results Three major themes: modifying—a necessary 
evil, nurses’ role as patient advocate and modifying—we 
are working very much as a team and two minor 
themes: fractional dosing, and covert administration 
emerged from the data. Nurses viewed oral medicine 
modifications as being a routine and necessary occurrence 
in geriatric patient care due to limitations of available 
formulations and the presence of age-related challenges 
in drug administration. Nurses’ knowledge of residents’ 
requirements ensured that they advocate for those with 
individualised formulation needs, however, nurses rely on 
pharmacists for information about modifications. Nurses 
expressed a desire for supports including increased 
education and ward-specific, pharmacist-developed 
recommendations on common modifications.
conclusions This study has provided useful insights into 
the views of nurses regarding oral medicine modification 
for older adults. The unique and varied formulation 
requirements of older adults must be acknowledged. 
Increased engagement by healthcare professionals, 
the pharmaceutical industry, regulatory agencies and 
policy-makers is required to facilitate the development 
of age-appropriate formulations. In the interim, practical 
interventions, informed by the findings of this study, are 
required.
IntrODuctIOn 
Medication administration is guided by a 
number of principles, with the ultimate 
aim of ensuring that the right medication 
is administered to the right patient at the 
right dosage, in the right form and at the 
right time.1 2 Given the global trend towards 
an ageing population,3–5 combined with 
the high rates of medication use among the 
older cohort,6 7 there is widespread recogni-
tion of the need to optimise medication use 
for older adults.8 9 However, various age-re-
lated changes, including dysphagia10–12 and 
altered pharmacokinetics (rate and extent 
of drug absorption, distribution, metabolism 
and excretion) and pharmacodynamics (the 
action/effect of a drug on the body),13 14 can 
complicate the administration of the right 
form or the right dose of oral medication to 
older adults. This may result in oral dosage 
forms (ODFs) being modified (eg, tablets 
crushed or split or capsules opened) to facil-
itate administration to patients with diffi-
culty swallowing or to tailor the dose to the 
patient’s requirements. Quantitative studies 
investigating medicine modification for 
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Research
strengths and limitations of this study
 ► The aim of this study was to use qualitative 
methodology to gain a greater understanding of the 
knowledge, attitudes and beliefs of nurses about the 
modification of oral medicines for older adults.
 ► Thematic analysis, using an inductive approach to 
coding, facilitated the generation of rich, in-depth, 
detailed accounts of nurses’ views in which the 
voice of the nurse was given primacy.
 ► This study was unique as it provided a greater 
insight into the range of modifications encountered 
in geriatric care than has previously been reported 
due to the inclusion of both acute and long-term 
care settings and the investigation of modifications 
to overcome swallowing difficulties and to meet 
patient’s dosing requirements.
 ► The study was conducted in the Munster province, 
in the south of the Republic of Ireland, with a 
population of almost 1.3 million. This may limit 
the transferability to other countries; however, the 
findings would be transferable to other countries with 
similar medication licensing and reimbursement 
procedures.
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older adults have highlighted the prevalence of this prac-
tice, as 18% of all residents in two Australian aged care 
facilities (n=160) received crushed tablets,15 while in a 
French study, completed in all geriatric units of a univer-
sity hospital, of the 683 patients included in the study, 
32% received crushed tablets or opened capsules.16 Data 
on tablet splitting for geriatric populations are limited; 
however, a Canadian study involving 370 nursing home 
residents found that 35% of residents received at least 
one split medication.17 A study undertaken in an Irish 
nursing home setting that investigated any modification 
of an ODF for 111 residents found that 35% of residents 
received at least one modified medication.18 Modifications 
have also been widely reported in the literature as being 
undertaken to facilitate covert administration of medi-
cation.19 20 This practice has recently been the focus of 
many policy documents in healthcare given the legal and 
ethical implications of covert administration.1 21 22 Covert 
administration is not the primary focus of this study, 
rather the study aims to investigate modifications of oral 
medicines to meet the needs of older patients in general.
Modifications of ODFs are of concern for healthcare 
professionals as they can potentially affect therapeutic 
outcomes for patients and adverse events have been 
reported as a consequence of medicine modification.23 24 
There are numerous potential mechanisms by which ODF 
modifications may alter drug action and therefore, thera-
peutic outcomes. Administration of a portion of a dosage 
form, for example, half a tablet, may result in inaccurate 
dosing.25 Modifications, for example, crushing tablets 
and opening capsules, may alter the site, rate or extent 
of drug absorption in vivo, which could result in either 
lower drug levels and lack of efficacy or alternatively, an 
increase in drug levels and associated toxicity.26 27 From 
a regulatory viewpoint, modifications generally void 
the product licence which can have significant implica-
tions for healthcare professionals in the event of adverse 
events.1 28 Nonetheless, modifications of oral medicines 
are prevalent among older patients.15 17 18 29 Qualitative 
study methodologies can be used to gain a deeper under-
standing of the factors that influence this practice in 
healthcare.30 A number of qualitative studies have inves-
tigated medicine modification31–33; however, a recent 
systematic review of qualitative literature highlighted the 
need for further research in this area given the limited 
number of studies.34 ‘The activities associated with medi-
cation management involve the nursing, midwifery, medi-
cine and pharmacy professions and the patient/service 
user’,1 however, ultimately nurses bear responsibility for 
medicine administration and therefore, perform modifi-
cations and administer modified medicines, in acute and 
long-term care settings. Despite this, only two previous 
qualitative studies investigated nurses' views about medi-
cine modification: an interview study conducted with 
nurses working in nursing home settings33; and a focus 
group study, which investigated the experiences of health-
care professionals (including five nurses) of the challenges 
encountered in medicine administration to patients with 
dysphagia.31 33 Investigation of the views and experiences 
of nurses about ODF modification will enable a greater 
understanding of the factors influencing this practice and 
the challenges encountered by nurses and patients on a 
daily basis. Increased understanding of these factors will 
aid the identification of potential areas for prioritisation 
for intervention and further research. This study contrib-
utes to, and further develops, the evidence base in this 
area, given the inclusion of nurses working in acute and 
long-term care and investigation of all types of ODF modi-
fications, including fractional dosing.
The aim of this study was to examine the knowledge, 
attitudes and beliefs of nurses about the modification of 
ODFs for older adults (aged ≥65 years).
MethODs
study design
Semi-structured interviews were conducted with nurses 
who provide care for, and administer medicines to, older 
adults (aged ≥65 years) within the Munster province in 
the south of the Republic of Ireland.35 Semi-structured 
interviews were chosen as the data generation method 
as rich, in-depth, detailed accounts of participant’s expe-
riences, perspectives and opinions can be gained. In 
addition, one-to-one interviews are particularly suited 
for discussing sensitive issues, such as individual nurse’s 
medicine administration practices.30
study setting and sampling
Purposive sampling, which involves actively selecting 
the most productive sample to answer the research 
questions,36 was used for site identification. A sampling 
matrix of important variables was developed to ensure 
that the range of sites providing care for older patients 
were included. Long-term care settings from each cate-
gory (public, private and voluntary (publicly funded but 
governed by a religious or charitable organisation))37; 
both with and without specialist dementia units were 
actively sampled.38 Previous research has shown that 
ODF modifications are more common in high depen-
dency units.29 According to the Department of Health, 
the public nursing home sector in Ireland has the highest 
proportion of maximum dependent older people at just 
over 60%, compared with private nursing homes where 
almost 35% of residents are maximally dependent.39 
Therefore, the funding category of the long-term care 
site was used as a surrogate descriptor for dependency. 
In addition, ODF modifications have been shown to be 
more common in dementia care units,15 providing the 
rationale for this variable. In the acute-care setting, both 
acute geriatric hospital wards and acute stroke wards were 
sought as previous studies have demonstrated that modi-
fications are commonly undertaken in wards of these 
types.40 41 Interview participants were identified by conve-
nience sampling of nurses within the purposively selected 
sites. Where possible, two of each type of care site, and at 
least one nurse from each site were sought for inclusion 
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box summary of topic guide for interviews
 ► Medicine administration to older adults
 ► Experience of medicine modification
 ► Knowledge about medicine modification
 ► Attitudes and beliefs regarding medicine modification
 ► Factors influencing practice
 ► Decision-making
 ► Information sources/resources used
 ► Healthcare professionals and their involvement
 ► Desire for any further resources/supports
in the study. For one category of long-term care site, only 
one such facility was available in the geographical area in 
which the study was conducted.
The medical director or nurse in charge at each of 
the purposively identified sites was contacted by tele-
phone or email and provided with details of the study. 
The person in charge approached individual nurses to 
identify potential participants. The inclusion criteria for 
interview participants was any nurse who provides care 
for, and administers medicines to, older adults (aged ≥65 
years) at the purposively selected sites. While healthcare 
assistants are also commonly employed in acute and long-
term care settings in Ireland, their responsibilities centre 
on personal care and do not usually extend to medication 
administration. Therefore, in an Irish setting, nurses are 
responsible for medicine administration, providing the 
rationale for choosing nurses as the interview participants 
for this study. It was highlighted to nurses that participa-
tion was voluntary and no incentive for participation was 
offered. When a nurse expressed an interest in partici-
pating, the primary researcher (AMG) followed up with 
a telephone call to arrange a convenient time for the 
interview.
Data collection
The topic guide was developed by the authors based on 
a review of the literature,34 observations from a preva-
lence study18 and the authors’ practical knowledge of the 
research area. The topic guide was modified following 
piloting with an experienced geriatric nurse who 
provided feedback on the content and language. This 
pilot interview was not included in the analysis. The topic 
guide underwent iterative revision throughout the study, 
to ensure that emerging themes were captured in subse-
quent interviews. Box provides a summary of the topic 
guide.
All semi-structured interviews were conducted by AMG, 
a research pharmacist with training in qualitative research 
methods and qualitative interviewing techniques. No 
relationship between the interviewer and participants 
was established prior to study commencement. The inter-
views were conducted in a private area at the participant’s 
workplace between March 2016 and February 2017. Only 
the interviewer and participant were present during the 
interview. All participants provided written informed 
consent for participation. Prior to initiating the interview, 
participants completed a demographic data collection 
form which recorded details including participant’s 
gender, age, qualifications, length of time working with 
older patients and details of any specific training under-
taken in medicine administration. The interviews were 
audio-taped and transcribed verbatim by AMG. Tran-
scripts were not returned to participants for comment 
and repeat interviews were not conducted. The inter-
viewer recorded any relevant field notes after conducting 
the interview.
The method used by Francis et al42 was used to deter-
mine when data saturation had been reached. An initial 
analysis sample of 15 and a stopping criterion of three 
were specified a priori. The initial analysis sample was 
determined based on the prespecified stratification 
factors in the sampling matrix, which sought to recruit at 
least one nurse from each purposively selected study site. 
The stopping criterion of three required that a further 
three consecutive interviews were conducted, in which no 
new concepts emerged, to confirm that data saturation 
had been achieved.
Analysis
The ‘Thematic Analysis’ approach, as described by Braun 
and Clarke,43 was used to analyse the data. The data (tran-
scripts) were inputted into QSR International’s NVivo 
V.10 Qualitative Data Analysis Software to facilitate anal-
ysis. Thematic analysis involves six phases: familiarisation 
with the data, generation of initial codes, searching for 
themes, reviewing themes, defining and naming themes 
and producing the report. Data familiarisation began 
at an early stage with data transcription, reading and 
rereading of the data. Open coding (phase II) was under-
taken by one author (AMG) to generate initial, non-hier-
archical codes. These initial codes were then categorised 
and re-ordered to generate potential themes. The next 
step involved reviewing and refining the themes gener-
ated in phase III. The fifth stage involved further analysis 
to refine the themes and to generate clear definitions and 
names for each theme. The final stage involved drafting 
the report. Participants were not asked to provide feed-
back on the study findings.
To ensure that codes were applied consistently, a coau-
thor (MK) independently coded a random sample of 
three interview transcripts. The inter-rater reliability 
between coders was determined by calculating the kappa 
coefficient for interviews coded by AMG and MK. The 
kappa coefficient measures the level of agreement, and 
ranges from 0 to 1; with 1 indicating perfect agreement 
and 0 indicating no agreement.44 In addition, each of the 
coauthors (LJS, AMC and MK) read six interview tran-
scripts to assess if the themes were reflective of the inter-
view content, to further ensure the confirmability of the 
findings.
reflexivity
The research team sought to address reflexivity during 
the design of the study. All four authors are pharmacists, 
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Table 1 Characteristics of interview participants (n=18)
Characteristic N (%)
Gender
  Male 3 (17%)
  Female 15 (83%)
Age group (years)
  20–29 1 (6%)
  30–39 10 (56%)
  40–49 2 (11%)
  50–59 4 (22%)
  60–69 1 (6%)
Nurse profession
  Staff nurse 4 (22%)
  CNM 1 1 (6%)
  CNM 2 5 (28%)
  Assistant Director of Nursing 1 (6%)
  Nurse (not specified) 7 (39%)
Care setting (n=16)
  Public LTCF with SDU (n=2) 2 (11%)
  Public LTCF without SDU (n=2) 2 (11%)
  Voluntary LTCF with SDU (n=1) 1 (6%)
  Voluntary LTCF without SDU (n=2) 2 (11%)
  Private LTCF with SDU (n=3) 3 (17%)
  Private LTCF without SDU (n=2) 2 (11%)
  Geriatric ward in acute hospital (n=2) 4 (22%)
  Stroke ward in acute hospital (n=2) 2 (11%)
Medicine administration training completed
  Yes 17 (94%)
  No 1 (6%)
Medication administration training mentioned included: on-site 
medication management training courses, refresher courses, on-
line training, undergraduate training, pharmacy-provided training.
CNM, Clinical Nurse Manager; LTCF, long-term care facility; SDU, 
specialist dementia unit.
and all are female. Two are academic staff members 
(one in clinical practice and one in pharmaceutics) 
and at the time of the study, the other two researchers 
were PhD students (both in clinical practice). None of 
the researchers was employed at any of the study sites 
and they had no prior relationship with any of the indi-
vidual nurses who participated in the study. All members 
of the research team have been involved in research 
investigating medicine modification for older adults. 
The research team discussed their preconceptions and 
thoughts about the research area and all felt, based on 
their previous experience, that medicine modification 
was likely to be encountered by nurses in geriatric patient 
care. However, all the research team acknowledged that 
they were unaware of the challenges encountered when 
physically performing medicine administration and 
modification as none had any previous practical expe-
rience in this area. Therefore, the views of nurses were 
given primacy and an inductive approach was seen to be 
most appropriate.
reporting
This study is reported in accordance with the Consolidated 
Criteria for Reporting Qualitative Research (COREQ) 
guidelines.45
results
characteristics of interview participants
Eighteen interviews were conducted in total. The inter-
views ranged in length from 7 to 31 min, with a mean 
interview duration (SD) of 16 min (6 min). Twelve of 
the interviewed nurses worked in long-term care and six 
worked in acute care. Of the nurses who participated in 
the study, 83% were female. The median age of partic-
ipants was 38 years (IQR 32.5–52.0). Seventeen nurses 
provided details about their experience caring for older 
people and the median length of experience in geriatric 
nursing was 8 years (IQR 5.0–11.5). Table 1 describes the 
characteristics of the interview participants.
Intercoder reliability
A Cohen’s kappa score of 0.924 was obtained which 
demonstrated aligned thinking between coders. In addi-
tion, following review of the themes in relation to inter-
view content, all authors agreed that the themes generated 
were representative of the content of the interviews.
themes
Three major themes emerged from the data: modify-
ing—a necessary evil, nurses’ role as patient advocate, 
modifying—we are working very much as a team. In addition, 
two minor themes emerged: covert administration, and 
fractional dosing. In order to comprehensively discuss 
nurses’ views on the topic of medicine modification, these 
two minor themes will be briefly addressed.
Major themes
Modifying—a necessary evil
Modifications of oral medicines were viewed by partic-
ipants as being a routine and necessary part of clinical 
practice and were undertaken on a daily basis as part of 
drug rounds. It was strongly felt that the older cohort in 
particular require modified medicines more frequently, 
“To be honest I think that modifying medicines is a neces-
sity, especially in elderly patients” (Nurse 2, Long Term 
Care (LTC)), “It would be very common here in the unit. 
It’s a geriatric ward. it would be very common I suppose 
here because of our patient group” (Nurse 10, Acute Care 
(AC)). Participants discussed a number of different types 
of modifications that they encountered, including tablet 
crushing, capsule opening, tablet splitting, dispersing 
or dissolving tablets and mixing medications with food. 
However, the modification that was reported as being 
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most common was tablet crushing, “In 95% of cases 
when we are talking about modifying medicines we are 
talking about crushing” (Nurse 5, LTC). The neces-
sity to modify medications was seen to be an inevitable 
part of older patient care and participants highlighted 
common reasons for this including: swallowing difficul-
ties or dysphagia, medical conditions with dysphagia as a 
sequela, patient preference or difficulty with large dosage 
forms, family input and formulation characteristics. 
Overall, age-related swallowing difficulties and dementia 
were the most commonly implicated reasons for ODF 
modification. It was clear from the interviews that formu-
lation suitability is extremely individualised, “all patients 
are so different… so you’d be looking at lots of different 
types of medications… whatever fits in with the individual 
patient” (Nurse 9, AC) and it is vital that each patient’s 
needs are assessed on a regular basis due to the potential 
for fluctuations in formulation suitability,
…you can see progressively the swallow or the level 
of cognition fluctuates, that affects the swallow and 
it’s something that you are looking at and thinking, 
oh my god (sic), this patient actually was taking oral 
tablets a matter of weeks ago and now it’s a case of 
that we’re dispersing them and giving them different 
suspensions… we are just keeping an eye out for 
ourselves[nurses watch for changes in patient’s ability 
to take different mediciation formulations] (Nurse 9, 
AC).
Participants reported that alternative formulation 
options are investigated when patients experience 
difficulty with solid ODFs. Options discussed included 
changing the route of administration or the formulation 
of the medication for example, liquid formulations, trans-
dermal patches, dispersible tablets, etc. The availability of 
appropriate alternative formulations was satisfactory for 
certain classes of medications, for example, antibiotics and 
antidementia medications; and participants expressed 
that in many instances the use of these alternatives was 
preferable to modifying oral medicines. However, there 
was an almost universal acknowledgement that there were 
significant limitations associated with alternatives that 
often resulted in modifications of ODFs being required 
or even preferred including: lack of availability or diffi-
culty sourcing alternatives; cost; alternatives not being 
covered on reimbursement schemes; difficulties adminis-
tering large or small volumes and issues with the viscosity 
of the liquids that may increase the risk of aspiration, “…
then we have liquid forms, again it’s hard to give liquid 
form medications to people with swallowing difficulties 
because of aspiration” (Nurse 13, LTC).
Participants expressed a wide variety of attitudes and 
beliefs about ODF modification. As stated, it was clear 
that the majority of participants felt that modifications 
were a routine part of practice. Participants highlighted a 
number of benefits of modifying ODFs including ensuring 
that vital medications are administered and overcoming 
concerns about not modifying medications, for example, 
the risk of choking or discontinuation of necessary medi-
cation, “Your choice is … crush the medicine which is 
what we do. or give the medication in its uncrushed form 
and run the risk of the person choking on it or not give 
the medicine at all and then, you know, the risk of the 
illness that’s treating” (Nurse 5, LTC). However, notwith-
standing the general acceptance of modifications as a 
routine occurrence, participants reported numerous 
concerns about modifications including: inaccurate 
dosing, altered drug absorption or effectiveness, poten-
tial interactions with food vehicles used for administra-
tion, possible cross-contamination issues, occupational 
hazards for nurses due to exposure to powdered drugs 
and the unlicensed nature of the modified medicines,
Sometimes I question it because… you crush all 
the tablets, they are all kind of going into one, you 
know, one dust…so are you modifying you know… 
the chemistry or what the tablet actually does because 
each tablet is made up individually… Plus, I don’t 
know are they getting the full dose of what they 
should be getting, because obviously there is going 
to be residue inside in the crush pouch that you can’t 
ever get out, and also… some in the yoghurt, or in the 
yoghurt tin or whatever you mix it in. So am I’d say 
they probably don’t always get the right dose (Nurse 
13, LTC).
An additional issue identified by nurses was the 
time-consuming nature of modifications, which impacted 
on nurses’ time and work-load, on the patient receiving 
the modified medicine and on other patients in the ward, 
“It definitely affects nurse’s time…we have a resident 
here … it takes twenty minutes to finish only that patient 
because everything needs to be crushed individually and 
you have to give everything individually. So it takes a good 
bit of time from you…that will affect the other patients as 
well… time is everything” (Nurse 1, LTC).
Overall, it is clear that nurses view modifying ODFs as 
a key part of their medication administration role. While 
nurses are aware that modifications may not be appro-
priate and did express concerns about the effect of modi-
fications on drug action, it is accepted that to meet the 
many individualised and varied needs of older patients, 
medicine modifications are a necessity, “Look it’s essen-
tial….it’s a necessary evil… I’m all for modifications 
because it’s necessary” (Nurse 4, LTC)
Nurses’ role as patient advocate
Medicine administration was acknowledged by partic-
ipants as being a key aspect of their role and nurses 
viewed medicine administration as their area of exper-
tise. However, from the interviews, it was clear that the 
responsibilities of nurses extended far beyond simply 
modifying and administering the medication. Nurses are 
at the frontline of healthcare provision and play a central 
role in every aspect of patient care related to medicine 
modification. Nurses: identify when patients are expe-
riencing difficulty swallowing medications; arrange 
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review by appropriate healthcare professionals; highlight 
patient’s requirements and needs to other healthcare 
professionals, especially doctors and pharmacists when 
prescribing and dispensing and communicate and liaise 
both with and between members of the multidisciplinary 
team. Therefore, the input of nursing staff is crucial in the 
area of medicine modification, “Very much nurse led…” 
(Nurse 6, LTC). The importance of nurses knowing their 
patients was central to this, “…one of the huge advan-
tages of working in care of the older person in long term 
settings is that you really get to know the patient…” (Nurse 
7, LTC). Nurses, particularly in long-term care, know the 
patients, and therefore their preferences and require-
ments, extremely well, “the most important thing is to 
know the person, know each individual” (Nurse 8, LTC). 
Nurses are also alert to subtle changes in the patient that 
may suggest that the patient is experiencing difficulty, 
“… as their medical condition changes… they’ve become 
unwell and we know that, you know, they’re coughing 
a lot or that their swallow has changed or that they’re 
not able for their big medications, it’s because we know 
our patients so well I suppose” (Nurse 17, LTC). Partic-
ipants did acknowledge that although some healthcare 
professionals do consider patient’s formulation require-
ments, particularly those who know the patient or geri-
atric specialists, overall there was a reliance on nurses to 
communicate patient’s formulation requirements. Nurses 
were cognisant of this responsibility and were particularly 
aware of highlighting this to out-of-hours doctors, “Espe-
cially [out-of-hours GP service] you have to be there on 
top of them saying no, this person is liquid, this person 
is, you know, suspension or whatever” (Nurse 6, LTC) and 
locum nursing staff. Nurses also shoulder responsibility 
for liaising between the various members of the multidis-
ciplinary team and communicating various recommenda-
tions within the team as often the multidisciplinary team 
members communicate through the nursing staff rather 
than directly, “The pharmacist will do a review, the phar-
macist leaves instructions, I communicate them to the 
GP” (Nurse 17, LTC).
It was evident that care provision in the area of medi-
cine modification is very much nurse-led and nurses play a 
central role in this area. Nurses appeared to be confident 
in exercising these responsibilities and at the centre of 
this was their acknowledgement that knowing the patient 
and developing a good relationship with them is a key 
component of their role. This allows nurses to act as an 
advocate for their patients. For nurses, acting as an advo-
cate for their patient’s, is an intrinsic component of their 
professional responsibility and identity “…none of them 
can speak for themselves, so you have to have somebody 
that knows them to be able to” (Nurse 8, LTC).
Modifying—we are working very much as a team
Nurses believed that decision-making around medicine 
modification requires the input and expertise of many 
different members of the multidisciplinary team. Nurses 
repeatedly highlighted the importance of ensuring that 
modifications are safe and appropriate “So we’d always 
make sure that if we’re crushing tablets that it’s safe to 
do so” (Nurse 18, AC). Nurses throughout the inter-
views demonstrated knowledge that certain formulations 
should never be modified, for example, sustained-release 
and enteric-coated preparations, which was based on their 
previous experience with such medications, “We’d know 
as well… the slow release, long acting, enteric coated or 
retard medicines… that we couldn’t be crushing them” 
(Nurse 14, LTC). Ultimately however, nurses acknowl-
edged that drug formulations and modification appropri-
ateness was not their area of expertise, “We would always 
seek external advice for that because that’s not our area 
of expertise" (Nurse 7, LTC), and that they always sought 
information and advice prior to modifying oral medi-
cines, “I always say it, I’m not a pharmacist and I’m not a 
doctor and I think it’s something that, I’m very cautious 
by nature anyways, am so it’s something I always double 
and triple check” (Nurse 9, AC).
The main information source for nurses about the 
modification of oral medicines and the availability of 
alternative formulations was the pharmacist, “It is always 
the pharmacy” (Nurse 7, LTC). Nurses reported relying 
on information provided by the pharmacist, “If I have 
any concerns I always ring the pharmacist and I always go 
by their directions…but always check with the pharma-
cist” (Nurse 2, LTC), “That would be a rule that we just 
don’t go off modifying the tablets ourselves, we have to 
do it in liaison with the pharmacy department so that we 
know…… the patient is getting the benefit of the medi-
cation, it is not altering the effectiveness of the drug and 
that it’s safe for the patient” (Nurse 10, AC). In general, 
nurses had very positive views of pharmacists, “Our phar-
macists are excellent. They are very accommodating to 
us” (Nurse 3, LTC) and pharmacists were seen to be the 
most knowledgeable member of the multidisciplinary 
team in relation to modifications, “On a Sunday or a bank 
holiday, you could discuss it with the medical team on call 
but often… regs [registrars] will tell you really to refer 
to the pharmacy department as soon as possible because 
I suppose, they’ve the most knowledge in relation to 
medication, the altering and modifying of them” (Nurse 
10, AC). One nurse did express dissatisfaction with the 
support provided by a pharmacy in the past, “There was 
one pharmacy alright that were a bit slack that I worked 
with” (Nurse 6, LTC). However, this reliance on pharma-
cists did present challenges in acute-care settings when 
the pharmacy department is closed, “We don’t have any 
24 hour pharmacy… you know so it may not be appro-
priate forms, it could be whatever you can get” (Nurse 
15, AC).
Nurses did mention a number of reference sources, for 
example, British National Formulary, Monthly Index of 
Medical Specialities (MIMS) and Summary of Product 
Characteristics; however, these resources did not provide 
information related to medicine modification “And it’s 
not really in the MIMS either… it doesn’t say whether you 
can crush it or not” (Nurse 16, LTC). In one acute-care 
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setting, a ward-specific guideline on medicine modifica-
tion was developed by the pharmacy department, which 
was mentioned as a useful resource available at the 
moment of medication administration, “Just definitely, 
that do not crush book, that’s like our bible here” (Nurse 
12, AC).
The attitudes of interview participants differed 
regarding the need for more resources and supports. 
Many of the participants expressed satisfaction with the 
supports and systems in place in their workplace. The 
majority of participants reported that they had very 
good working relationships with other members of the 
multidisciplinary team and they valued a collaborative 
approach to decision making in which their opinions 
were listened to and accepted, “We have a very good 
working relationship but generally they don’t question, 
they accept, you know, our judgement on it I suppose” 
(Nurse 5, LTC). Notwithstanding this finding, some 
participants did discuss a number of potential methods 
of improving multidisciplinary collaboration including: 
the multidisciplinary team meeting to review and discuss 
patient’s needs and greater consideration being given 
to patient’s formulation requirements by doctors and 
pharmacists when prescribing or dispensing, “I suppose, 
as a multidisciplinary, sitting down as a nurse, GP and 
pharmacist together… there isn’t enough constructive 
reviewing of that, it’s very much the GP does the monthly 
round, the script goes to the pharmacist, the pharmacist 
sends it up and the follow-up really is the nurse” (Nurse 
7, LTC). Some participants also expressed a desire for 
auditing of their medication administration practices, “I 
suppose observing how we are doing it because again, you 
can’t constructively say right that’s the correct procedure 
unless you actually observe it yourself” (Nurse 7, LTC). A 
number of other suggestions were mentioned including: 
more education and training from pharmacists and avail-
ability of a pharmacy-developed site-specific formulary 
or online database on commonly encountered modifi-
cations, “I think all nurses should be given extra phar-
macy education, especially in specialist areas where we 
are doing a lot of modifications” (Nurse 9, AC), “A phar-
macy-led manual on the ward where, whatever amount 
of medications they can go through, whether they state 
whether this medication could be crushed or halved or 
dissolved in water or whether, you know, it is readily avail-
able in that particular hospital in liquid form” (Nurse 
10, AC). Nurses also stated that increased availability of 
alternative formulations and increased recognition by the 
pharmaceutical industry of the formulation challenges 
encountered by older patients on a daily basis would be 
welcome.
Minor themes
Fractional dosing
Fractional dosing involves the administration of part of a 
dosage form, for example, half a tablet, to facilitate the 
administration of a lower dose. While score lines are often 
present on tablets, in many instances these score lines 
do not divide the tablet into equal doses but rather 
allow tablets to be split to facilitate swallowing. When 
participants were asked to discuss the common modi-
fications they encountered in practice and the reasons 
for undertaking modifications, none of the participants 
volunteered fractional dosing. While splitting tablets was 
commonly mentioned, this was to overcome difficulty 
swallowing large tablets rather than for fractional dosing. 
However, when participants were specifically asked about 
modifications for fractional dosing, it was viewed as 
being frequently undertaken for older patients, “Yeah, 
daily … some of the medication that we give out on a 
daily basis doesn’t come in a dose that’s prescribed” 
(Nurse 11, AC). Fractional dosing was felt to be neces-
sary for older adults due to a combination of increased 
sensitivity to higher doses and a corresponding lack of 
commercial formulations that meet these dosing require-
ments, “I see a lot more of it here [fractional dosing on 
a geriatric ward]…you would find that they’re constantly 
altering doses because some of them might be too severe, 
patients don’t react well and it’s always finding the fine 
balance to keep some of the patients on an even keel” 
(Nurse 9, AC), “…splitting the tablet because the form, 
the dosage wouldn’t be available, especially with the 
anti-hypertensive tablet, we always split it or quarter it” 
(Nurse 1, LTC). Drugs acting on the central nervous 
system, especially quetiapine, and the cardiovascular 
system were the most commonly implicated medica-
tions, “Seroquel … comes in a 25 mg tablet. That has to 
be split for 12.5. Yet 12.5 is the most common dose… 
but there is no 12.5 available” (Nurse 6, LTC). Fraction-
ally dosed medications were often supplied presplit by 
the pharmacy, which seemed to account for nurses not 
considering this a modification as they did not physically 
perform the modification themselves, “The pharmacy 
will do the alteration if they are required, we don’t do 
it at floor level no” (Nurse 17, LTC). In addition, there 
was a general belief that scored tablets are designed to 
be split in two for fractional dosing, “I mean many tablets 
as you know are scored to be divided in two” (Nurse 5, 
LTC). However, some nurses did report checking with 
pharmacy colleagues whether fractional dosing was 
appropriate, even for scored tablets. While overall partic-
ipants did not have many concerns about administering 
fractionally dosed medications, particularly if the phar-
macy had split the tablets in advance or the tablets were 
scored, a number of concerns were raised including inac-
curate dosing, wastage and difficulties splitting tablets, 
“How accurate is the dose?… like, as somebody said to 
me ‘I gave him the big half’. Yeah, that says everything” 
(Nurse 6, LTC). Overall, participants’ attitudes to the 
modification of medications for fractional dosing were 
distinct from attitudes to modifications due to swallowing 
difficulties or patient preference. This appeared to be 
related to lack of knowledge about the purpose of score 
lines on tablets and different attitudes towards modifica-
tions when tablets are presplit by the pharmacy.
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Covert administration
The modification of medicines to facilitate covert admin-
istration was mentioned by a number of participants and it 
would be remiss not to address this as a separate theme. A 
number of participants acknowledged that covert admin-
istration was commonly undertaken in the past, partic-
ularly for patients with dementia or agitated patients, 
“Now I would admit, I’m a long time in the profession, 
certainly that has happened in the past” (Nurse 5, LTC). 
The majority of participants who discussed covert admin-
istration stated that it was not undertaken at their site of 
employment, “Now, it’s not actually done in this hospital” 
(Nurse 6, LTC) and that it is no longer commonly 
encountered. The ethical implications of covert adminis-
tration and the importance of respecting patient’s wishes 
was a major factor influencing this, “Oh no, no, we would 
never… if a patient refuses that’s it… the law as you may 
know, says no means no. And no even means no from 
somebody who is cognitively impaired” (Nurse 5, LTC). 
There was an acknowledgement that very occasionally, 
covert administration occurs but that this is undertaken 
in strict adherence to detailed policies and guidelines 
on covert administration, following discussion with all 
members of the multidisciplinary team and the patient’s 
family and taking the importance of the medication into 
consideration, “We have a policy around it and I suppose 
it would have to be in the person’s best interest whether 
they need the tablet or not” (Nurse 16, LTC). The main 
challenge discussed by nurses relating to covert adminis-
tration was the ethical dilemma that arose when trying to 
balance respecting patient’s wishes and providing optimal 
medical and pharmacological care to individual patients.
DIscussIOn
This study has identified the knowledge, attitudes and 
beliefs of nurses about the modification of oral medi-
cines for older adults using qualitative, semi-structured 
interviews. Three major themes emerged from the data: 
modifying—a necessary evil; nurses’ role as patient advo-
cate; modifying—we are working very much as a team. The 
findings of this study provide important insights that will 
enable us to better understand ODF modification prac-
tices and the challenges that need to be addressed to opti-
mise formulation suitability for older adults.
From the results of this study, it is clear that nurses view 
ODF modifications as being a necessity in the care of 
older patients. While a myriad of factors contributed to 
this, one of the most important influences was the belief 
that formulation suitability is extremely individualised 
and varies significantly between patients due to medical 
conditions, patient preference, severity of dysphagia and 
the clinical status of the patient. This finding concurs 
with a recently published systematic review on the views 
of healthcare professionals and patients about medicine 
modification which found that patient-centred individu-
ality and variability was a key driver of ODF modification.34 
While it was noted that alternatives to solid ODFs are often 
simply not available, it was also highlighted that modifica-
tions are often preferred due to unsatisfactory properties 
of available alternative oral liquid formulations such as 
viscosity and the consequent risk of aspiration, expense, 
difficulties sourcing and difficulties administering the 
necessary volume. These reported challenging properties 
of alternative formulations echo the findings of previous 
qualitative studies.31 33 This study further develops the 
evidence base through the inclusion of nurses working in 
both acute and long-term care settings and also by investi-
gating modifications to facilitate fractional dosing which 
have been neglected in qualitative literature thus far. Data 
from quantitative studies have demonstrated that modi-
fications are prevalent,15 18 29 46 and alternative formula-
tions are often unavailable or unsatisfactory,18 47 which 
confirms the beliefs expressed by nurses about modifi-
cations. However, despite this reality, guidance provided 
to healthcare professionals generally advises that modi-
fications should be avoided.1 27 It is clear that this advice 
can be difficult for healthcare professionals to adhere to 
given limitations of currently marketed ODFs.
The nurses’ role as patient advocate was a strong theme 
present throughout the data. Familiarity with, and knowl-
edge of, the patient ensures that nurses have a vital role 
in identifying patients’ difficulties with oral formula-
tions and liaising with other healthcare professionals to 
address any issues. Previous studies have found that inad-
equate communication practices result in lack of aware-
ness of patient’s formulation requirements.34 48 This study 
has found that for patients in long-term and acute-care 
settings, nurses’ knowledge of the patient allows them 
to act as an advocate on the patient’s behalf which helps 
to overcome this communication deficit. This is particu-
larly true in long-term care given the length of stay. On 
acute geriatric wards, nurses spend more time on direct 
nursing care compared with many other ward types49 
and have more direct patient contact than any other 
healthcare professional, facilitating the development of 
the nurse-patient relationship. A key tenet of nursing 
care and the subject of much nursing literature is the 
concept of ‘knowing the patient’.50 51 The importance 
of the nurse-patient relationship has been suggested as 
being an important contributor to the individualisa-
tion of care provision and potentially improving patient 
outcomes.51 52 This finding has important implications for 
other members of the multidisciplinary team who should 
be encouraged to consult with nurses as they ‘know’ 
the patient prior to prescribing and dispensing medica-
tions for this cohort. A more formal, proactive review of 
patients, in the presence of all necessary members of the 
multidisciplinary team, was also mentioned as a possible 
method to optimise formulation suitability for individual 
patients in the absence of satisfactory alternatives. An 
approach such as this would ensure that all necessary 
expertise was available and would allow other healthcare 
professionals to benefit from the nurses knowledge of 
the individual and decrease the time spent by nurses in 
communicating recommendations from one healthcare 
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professional to another. Administrative tasks, such as 
these, can be time-consuming for nurses which takes 
time away from direct patient care.53 The importance 
of a patient advocate needs to be recognised by health-
care professionals, which has particular implications for 
community-dwelling patients. Studies have previously 
reported that healthcare professionals are frequently 
unaware of difficulties with medication intake experi-
enced by community-dwelling patients,54–56 which high-
lights the importance of enquiring about difficulties, 
either from the patient themselves or a suitable advocate 
who knows the patient, for example, a carer.
Some nurses in this study expressed a desire for resources 
and supports that would help them in their day-to-day 
practice. Nurses were reliant on pharmacists for informa-
tion provision regarding the appropriateness of medicine 
modification and satisfaction with pharmacists’ role was 
generally expressed. In addition, while not a major source 
of information, nurses also expressed satisfaction with the 
role of the doctor in their workplaces, who support nurses in 
ensuring that modifications are authorised on drug charts. 
Some nurses did express a desire for further education and 
training on the pharmacological and pharmaceutical impli-
cations of modification, and while they did acknowledge that 
this was not their area of expertise, some felt that increased 
knowledge would facilitate nurses to be more empowered 
in this area. There were variations in nurse knowledge 
displayed, which may serve as starting points for educational 
interventions, particularly in the area of capsule opening 
and fractional dosing. Knowledge about the purpose of the 
score line on tablets differed, with some nurses assuming 
that this score line was to facilitate fractional dosing and 
therefore, divided the tablets into two equal halves. This 
has been identified as an issue previously57 and regulatory 
agencies are becoming more concerned about the pres-
ence of non-functional score lines on tablets.58 59 This may 
highlight a potential role for education of nurses on rele-
vant, fundamental aspects of pharmaceutics (dosage form 
design). Nurses seemed to express a preference for phar-
macists to deliver such educational programmes. Another 
possible intervention suggested by nurses was the use of a 
pharmacist-developed, site-specific guidance document, 
which would provide recommendations on commonly 
encountered modifications within the care setting. One 
study site had such a resource and the participant found this 
to be extremely useful in their daily practice. Bourdenet et 
al40 found that the implementation of good practice recom-
mendations and the development of a list of medications 
that should not be modified resulted in a significant reduc-
tion in the number of patients receiving crushed medica-
tion and a significant reduction in crushing of drugs that 
should not be modified. While practical interventions such 
as this should be developed and evaluated in an attempt to 
support nurses and patients administer medications in the 
short-term, ultimately there is a need to increase the avail-
ability of licensed formulations that meet the needs of the 
older adult. Nurses advocate for individual patients in daily 
practice; however, the older cohort requires advocates to 
highlight their needs to industry, regulatory agencies and 
policy-makers, to encourage the development of age-appro-
priate formulations. Optimisation of formulation suitability 
for older adults will require a thorough understanding of the 
challenges of administering medication to older adults. The 
literature abounds with commentaries on the age-related 
challenges in medication administration.8 60 61 A growing 
body of evidence from clinical practice is required to quan-
tify the breadth of the problems encountered. However, 
to truly understand the challenges encountered, the views 
of healthcare professionals, patients and carers need to 
be heard to ensure that any potential solutions developed 
reflect the priorities and needs of end-users62 and there-
fore, will be of maximal benefit.62 This study adds to the 
existing evidence-base on the views of nurses about medi-
cine modification.31 33 In addition to the potential interven-
tions discussed above, further research should investigate 
the views of patients and their informal carers in community 
settings where there may be limited healthcare professional 
input into decision-making in relation to medicine modifi-
cation.54 55 This research should seek to identify the main 
challenges encountered by this cohort, and to determine 
the ‘ideal’ formulation characteristics from the perspectives 
of patients, carers and healthcare professionals.
There are a number of strengths associated with this 
study. The use of semi-structured interviews allowed 
for in-depth, detailed accounts of participants’ experi-
ences and perceptions to be elucidated.30 The data were 
analysed thematically,43 using an inductive approach to 
coding which produced rich findings that were firmly 
rooted in the data. The timeframe of the study also 
facilitated an iterative approach to data collection and 
analysis, which allowed a thorough interrogation of the 
data. The transferability of the study findings may be 
questioned given that the interviews were conducted in 
one geographical area in Ireland. However, the use of 
the sampling matrix helped to ensure that the views of 
nurses working in a variety of care settings were eluci-
dated, which helped to overcome this limitation. In 
addition, the findings cohered with the limited evidence 
from other qualitative and quantitative studies, which 
further confirm the transferability of findings. Social 
desirability is another potential limitation of the study. 
Participants were aware that the interviewer was a phar-
macist by background and the research team were all 
based at a School of Pharmacy, therefore, there is the 
possibility that the participants gave socially desirable 
answers. While it is difficult to eliminate this bias, the 
research team had discussed this prior to undertaking 
the study and felt that it would be unethical not to 
disclose the research team’s backgrounds. However, this 
was balanced by highlighting to participants that the 
research team were interested in hearing and gaining a 
greater understanding of the views and experiences of 
nurses. Social desirability did not appear to emerge as 
a significant issue given the honest, forthcoming nature 
of the interviews, with both positive and negative expe-
riences with pharmacy colleagues being reported and 
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discussed. In addition, nurses were asked to describe the 
procedure followed in their institution when medica-
tions were required to be modified for patients. Nurses, 
in different institutions, all described the input of phar-
macists and the role they played. The role of the phar-
macist was similar across all institutions included in the 
study, so it is likely that this reflects the true role that 
pharmacists play in an Irish setting. The length of the 
interviews ranged from 7 to 31 min. The shortest inter-
view was conducted on an extremely busy ward in an 
acute hospital, which is likely to have contributed to the 
brevity of this interview. However, useful insights were 
still gained in this interview. The interviews focused on 
oral medicine modification, which was clear to partic-
ipants from the information leaflet for the study. As 
a result, the discussions in the interviews centred on 
medicine administration and modification for older 
adults from the outset. Therefore, very detailed insights 
into this topic were gained from what could be consid-
ered to be relatively short interviews. The authors feel 
that the interviews provided comprehensive coverage 
of the topic and therefore the length of the interviews 
has not impacted on the quality or depth of findings of 
the study. It was not possible from the detail provided 
in the completed data collection forms to ascertain the 
primary nursing qualification of all participants due to 
variability in how nurses completed the data collection 
form. Regardless of qualification, all of the interview 
participants would be required to demonstrate their 
competency to, and register with, the Nursing and 
Midwifery Board of Ireland and adhere to the relevant 
national guidelines on medicine administration. In 
addition, the number of years working in care of older 
patients was recorded, but not the total number of years 
since qualification, as the former was of more interest 
for the purposes of this study. No variation in ideas or 
responses was observed between participants based on 
age, qualification type or length of experience in geri-
atric patient care. However, previous research has inves-
tigated how nursing competence relates to length of 
clinical experience.63 While in this study, similar themes 
and insights were gained irrespective of length of expe-
rience in geriatric patient care, future research should 
consider qualification type and time since qualification 
to investigate whether this affects practice.
cOnclusIOn
This study has provided a useful insight into the knowl-
edge, attitudes and beliefs of nurses on the modifica-
tion of oral medicines for older adults. Modifications 
of oral medications are viewed as unavoidable in care 
of the older person, due to limitations of available 
formulations. Nurses had a number of concerns about 
modifications and valued input from other healthcare 
professionals, particularly pharmacists. Nurses’ knowl-
edge of individual patients ensures that nurses have a 
vital role to play in identifying and assessing patients 
experiencing difficulty with oral medicines and in 
communicating with other healthcare professionals. 
The unique and varied formulation requirements 
of older adults must be acknowledged by healthcare 
professionals, academics, regulatory agencies, the phar-
maceutical industry and policy-makers to promote the 
development of more age-appropriate formulations. 
In the interim, practical interventions and guidance 
should be developed, taking into consideration the 
themes that were identified in this study.
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